Pharming Group NV (PHAR) — Cash Flow Reinvestment Rate
Latest as of March 2026:
0.15x
Pharming Group NV (PHAR) has a Cash Flow Reinvestment Rate of 0.15x as of March 2026, reinvesting $238.86K (capex $238.86K ) from operating cash flow of $1.63 Million. Explore PHAR capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.15x
(Capex + Investments) / Operating CF
Total Reinvested
$238.86K
Capex + Investments
Operating Cash Flow
$1.63 Million
USD
Capital Expenditures
$238.86K
USD
Pharming Group NV Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Pharming Group NV across 7 annual periods. Also explore PHAR asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Pharming Group NV (2017–2025)
Year-by-year capital reinvestment analysis for Pharming Group NV. For live market cap and broader valuation context, see Pharming Group NV (PHAR) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.72x | $85.97 Million | $50.07 Million | $751.09K | ▲ +428.3% |
| 2022 | 0.33x | $7.30 Million | $22.46 Million | $1.98 Million | ▼ -40.2% |
| 2021 | 0.54x | $20.59 Million | $37.84 Million | $16.72 Million | ▲ +191.8% |
| 2020 | 0.19x | $15.59 Million | $83.63 Million | $15.30 Million | ▼ -50.6% |
| 2019 | 0.38x | $27.95 Million | $74.15 Million | $25.45 Million | ▲ +155.5% |
| 2018 | 0.15x | $6.81 Million | $46.19 Million | $4.31 Million | ▼ -30.7% |
| 2017 | 0.21x | $9.76 Million | $45.84 Million | $7.25 Million | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow